đź’¨ Abstract
Lyell Immunopharma Inc. (LYEL) reported a first-quarter loss of $52.2 million, or 18 cents per share, surpassing Wall Street's consensus estimate of a 19-cent loss per share. The biotech firm generated $7,000 in revenue during the period.
Courtesy: wtop.com
Suggested
Indexes___________________________Close_____Dly Chg___Week Chg__Ytd Chg -
Indexes___________________________Close_____Dly Chg___Week Chg__Ytd Chg -
Indexes___________________________Close_____Dly Chg___Week Chg__Ytd Chg -
Gobierno de Trump recorta otros US$ 450 millones en subvenciones a Harvard y se suman a los US$ 2.200 millones ya congelados -
BYU promotes Brian Santiago to replace longtime athletic director Tom Holmoe -
California approves State Farm’s request for 17% premium increase for homeowners -
Indexes___________________________Close_____Dly Chg___Week Chg__Ytd Chg -
Indexes___________________________Close_____Dly Chg___Week Chg__Ytd Chg -
MLB reinstates Pete Rose and Shoeless Joe Jackson, making them Hall of Fame eligible -
Indexes___________________________Close_____Dly Chg___Week Chg__Ytd Chg -